These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 630799)

  • 1. Muscle electrolytes and fluid compartments in six children with Bartter's syndrome.
    Delaporte C; Stulzaft J; Loirat C; Broyer M
    Clin Sci Mol Med; 1978 Mar; 54(3):223-31. PubMed ID: 630799
    [No Abstract]   [Full Text] [Related]  

  • 2. Escape from sodium and potassium retaining actions of aspirin-like drugs used in a patient with Bartter's syndrome.
    Ishikawa Y; Wada T
    Jpn Circ J; 1979 Aug; 43(8):757-67. PubMed ID: 501898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular potassium transport and ATPase activity in Bartter's syndrome.
    Haljamäe H; Enger E; Sigström L
    Scand J Clin Lab Invest; 1975 Jan; 35(1):53-8. PubMed ID: 124092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tubular reabsorption of chloride in Bartter's syndrome and other conditions with hypokalemia.
    Rodriguez Portales JA; Delea CS
    Clin Nephrol; 1986 Dec; 26(6):269-72. PubMed ID: 3802593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exchangeable electrolytes, glycoregulation and growth hormone in one case of Bartter's syndrome (author's transl)].
    Lefebvre J; Racadot A; Dequiedt P; Linquette M
    Ann Endocrinol (Paris); 1977; 38(6):385-6. PubMed ID: 612271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bartter's syndrome].
    Tomita K; Shinohara S; Mito Y; Tomiyama O; Shiigai T; Kitaoka T
    Nihon Rinsho; 1979; 37(2):362-9. PubMed ID: 439425
    [No Abstract]   [Full Text] [Related]  

  • 7. [The defect in chloride reabsorption and influence of indomethacin in the renal tubules of Bartter's syndrome (author's transl)].
    Yasuda G; Shionoiri H; Hikuma K; Uneda S; Nagasawa T
    Horumon To Rinsho; 1981 Jul; 29(7):827-30. PubMed ID: 7307299
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total body potassium, skeletal muscle potassium and magnesium in patients with Bartter's syndrome.
    Rudin A; Bosaeus I; Hessov I
    Scand J Clin Lab Invest; 1990 May; 50(3):273-7. PubMed ID: 2353156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic studies in Bartter's syndrome: opposite effects of treatment with antikaliuretic and antiprostaglandin drugs. Part I.
    Simatupang TA; Radó JP; Boer P; Geyskes GG; Vos J; Dorhout Mees EJ
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):14-8. PubMed ID: 631965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated sweat potassium, hyperaldosteronism and pseudo-Bartter's syndrome: a spectrum of disorders associated with cystic fibrosis.
    Devlin J; Beckett NS; David TJ
    J R Soc Med; 1989; 82 Suppl 16(Suppl 16):38-43. PubMed ID: 2724265
    [No Abstract]   [Full Text] [Related]  

  • 12. The pathogenetic spectrum of Bartter's syndrome.
    Stein JH
    Kidney Int; 1985 Jul; 28(1):85-93. PubMed ID: 4046329
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the pathogenesis of Bartter's syndrome.
    Baehler RW; Work J; Kotchen TA; McMorrow G; Guthrie G
    Am J Med; 1980 Dec; 69(6):933-8. PubMed ID: 7446558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of hypokalemia in Bartter's syndrome].
    Takeda R; Fujimura A; Kigoshi T; Horigami T
    Nihon Rinsho; 1981 Feb; 39(2):343-7. PubMed ID: 7265480
    [No Abstract]   [Full Text] [Related]  

  • 16. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.
    Cunningham RJ; Brouhard BH; Berger M; Petrusick T; Travis LB
    Pediatrics; 1979 May; 63(5):754-6. PubMed ID: 440896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does defective chloride reabsorption at the loop of Henle play a major role in the pathogenesis of Bartter's syndrome?
    Milani L; Pessina AC; Maccà F; Pauletto P; Gatta A
    Am J Nephrol; 1987; 7(1):65-8. PubMed ID: 3578377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bartter's syndrome: clinical study of its treatment with salt loading and propranolol.
    Schwartz GJ; Cornfeld D
    Clin Nephrol; 1975 Aug; 4(2):45-51. PubMed ID: 1157350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome.
    Watson ML; Gill JR; Branch RA; Oates JA; Brash AR
    Lancet; 1983 Aug; 2(8346):368-70. PubMed ID: 6135873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.